Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Involvement of orexinergic system in psychiatric and neurodegenerative disorders: A scoping review
Hayder M. Al‐kuraishy, MayH Abdulhadi, NawarR Hussien, et al.
Brain Circulation (2020) Vol. 6, Iss. 2, pp. 70-70
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

The Orexin/Hypocretin System, the Peptidergic Regulator of Vigilance, Orchestrates Adaptation to Stress
Miklós Jászberényi, Balázs Thurzó, Zsolt Bagosi, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 448-448
Open Access | Times Cited: 22
Role of ketogenic diet in neurodegenerative diseases focusing on Alzheimer diseases: The guardian angle
Hayder M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102233-102233
Closed Access | Times Cited: 16
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Anamaria Jurcău
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1432-1432
Open Access | Times Cited: 61
A Potential Link Between Visceral Obesity and Risk of Alzheimer’s Disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 745-766
Closed Access | Times Cited: 53
Metformin role in Parkinson’s disease: a double-sword effect
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 4, pp. 975-991
Closed Access | Times Cited: 37
Parkinson’s Disease Risk and Hyperhomocysteinemia: The Possible Link
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaser Hosny Ali Elewa, et al.
Cellular and Molecular Neurobiology (2023) Vol. 43, Iss. 6, pp. 2743-2759
Open Access | Times Cited: 36
The link between metabolic syndrome and Alzheimer disease: A mutual relationship and long rigorous investigation
Haydar M. Al‐kuraishy, Majid S. Jabir, Ali K. Albuhadily, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102084-102084
Closed Access | Times Cited: 30
A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson’s disease: beneficial or detrimental effects
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 2, pp. 673-688
Closed Access | Times Cited: 27
The Role of Iron Metabolism, Lipid Metabolism, and Redox Homeostasis in Alzheimer’s Disease: from the Perspective of Ferroptosis
Linyu Wu, Xiao‐Hui Xian, Zixuan Tan, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 5, pp. 2832-2850
Closed Access | Times Cited: 25
The Molecular Pathway of p75 Neurotrophin Receptor (p75NTR) in Parkinson’s Disease: The Way of New Inroads
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 5, pp. 2469-2480
Closed Access | Times Cited: 24
Insights on benzodiazepines' potential in Alzheimer's disease
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Abdulrahman A. Alsayegh, et al.
Life Sciences (2023) Vol. 320, pp. 121532-121532
Closed Access | Times Cited: 23
Orexin pathway in Parkinson’s disease: a review
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6107-6120
Closed Access | Times Cited: 23
BDNF/TrkB activators in Parkinson's disease: A new therapeutic strategy
Naif H. Ali, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 14
The glymphatic system and Amyotrophic lateral sclerosis
Andrew Eisen, Maiken Nedergaard, E. G. Gray, et al.
Progress in Neurobiology (2024) Vol. 234, pp. 102571-102571
Closed Access | Times Cited: 8
The role of statins in amyotrophic lateral sclerosis: protective or not?
Hayder M. Al‐kuraishy, Majid S. Jabir, Ghassan M. Sulaiman, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 8
The potential role of brain renin‐angiotensin system in the neuropathology of Parkinson disease: Friend, foe or turncoat?
Zainah Al‐Qahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 12
Open Access | Times Cited: 6
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15
Compound B vitamins mitigate post-traumatic stress disorder-like behaviors induced by single prolonged stress in rats by inhibiting hippocampal mitochondrial DNA methylation
Yanteng Li, Runzi Wang, Fang Xie, et al.
Journal of Neurorestoratology (2025), pp. 100187-100187
Open Access
Dysregulation of serotonergic neurotransmission in Parkinson disease: A key duet
Manal M. Khowdiary, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177419-177419
Open Access
The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects
Saad Misfer Alqahtani, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
European Journal of Pharmacology (2025), pp. 177510-177510
Open Access
Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature
Al-Hassan Soliman Wadan, Ahmed Shaaban, Mohamed El‐Sadek, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study
Susana Lozano-Tovar, Riccardo Cremascoli, Marzia Nuccetelli, et al.
Neurological Sciences (2025)
Open Access
Irisin/PGC-1α/FNDC5 pathway in Parkinson’s disease: truth under the throes
Naif H. Ali, Nourah Alhamdan, Hayder M. Al‐kuraishy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 4, pp. 1985-1995
Closed Access | Times Cited: 11
Current Update on Clinically Relevant Sleep Issues in Parkinson’s Disease: A Narrative Review
Keisuke Suzuki
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 3, pp. 971-992
Open Access | Times Cited: 26
Role of orexin in pathogenesis of neurodegenerative parkinsonisms
Piotr Alster, Natalia Madetko, Dagmara Otto‐Ślusarczyk, et al.
Neurologia i Neurochirurgia Polska (2023) Vol. 57, Iss. 4, pp. 335-343
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top